EPISODE · Dec 31, 2024 · 48 MIN
Episode 47 - Marc Lajoie, CEO at Outpace Bio
from Few & Far Between: How Biotech Gets Built · host Chris O'Brien
"If you bring powerful technology to a problem that is well understood, then you can really make a difference." - Marc Lajoie, CEO at Outpace Bio Welcome to the latest episode of Biorasi's Few & Far Between podcast. Join host Chris O'Brien and guest, Marc Lajoie, as they discuss how de novo proteins can be used to reprogram immune cells. Tune in today!
Embed this episode
NOW PLAYING
Episode 47 - Marc Lajoie, CEO at Outpace Bio
0:00
48:25
1×
No transcript for this episode yet
Similar Episodes
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Few & Far Between: How Biotech Gets Built?
This episode is 48 minutes long.
When was this Few & Far Between: How Biotech Gets Built episode published?
This episode was published on December 31, 2024.
Can I download this Few & Far Between: How Biotech Gets Built episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!